An open-label, randomized, placebo-controlled study on the effectiveness of a novel probiotics administration protocol (ProbiotiCKD) in patients with mild renal insufficiency (stage 3a of CKD)

PURPOSE: Gut dysbiosis has been described in advanced, but not in initial stages of CKD. Considering the relevant impact of gut dysbiosis on renal and cardiovascular risk, its diagnosis and treatment are clinically relevant. METHODS: We designed, open-label, placebo-controlled intervention study (Pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Simeoni, Mariadelina, Citraro, Maria Lucia, Cerantonio, Annamaria, Deodato, Francesca, Provenzano, Michele, Cianfrone, Paola, Capria, Maria, Corrado, Silvia, Libri, Emanuela, Comi, Alessandro, Pujia, Arturo, Abenavoli, Ludovico, Andreucci, Michele, Cocchi, Massimo, Montalcini, Tiziana, Fuiano, Giorgio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2018
Materias:
Original Contribution
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6647244/
https://www.ncbi.nlm.nih.gov/pubmed/30076458
http://dx.doi.org/10.1007/s00394-018-1785-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6647244/
https://www.ncbi.nlm.nih.gov/pubmed/30076458
http://dx.doi.org/10.1007/s00394-018-1785-z

Ejemplares similares